1. |
1 Brammer R, Buckels J, Bramhall S. Advances in non
operative therapy in pancreatic cancer [J]. Int J Clin Pract, 2000; 54(6)3732 Graber HU, Friess H, Zimmermann A, et al. Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells [J]. J Gastrointest Surg, 1999; 3(1)743 Korc M. Role of growth factors in pancreatic cancer [J]. Surg Oncol Clin N Am, 1998; 7(1)254 Liao Q, Ozawa F, Friess H, et al. The antiapoptotic protein BAG3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines [J]. FEBS Lett, 2001; 503(2-3)1515 Makinen K, Hakala T, Lipponen P, et al. Clinical contribution of bcl2, p53 and Ki67 proteins in pancreatic ductal adenocarcinoma [J]. Anticancer Res, 1998; 18(1B)6156 Bold RJ, Hess KR, Pearson AS, et al. Prognostic factors in resectable pancreatic cancer: p53 and bcl2 [J]. J Gastrointest Surg, 1999; 3(3)2637 Ariapart P, BergstedtLindqvist S, van Harmelen V, et al. Resection of pancreatic cancer normalizes the preoperative increase of tumor necrosis factor alpha gene expression [J]. Pancreatology, 2002; 2(5)4918 Trauzold A, Wermann H, Arlt A, et al. CD95 and TRAIL receptormediated activation of protein kinase C and NFkappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells [J]. Oncogene, 2001; 20(31)42589 Takayama S, Xie Z, Reed JC. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators [J]. J Biol Chem, 1999; 274(2)78110 廖泉,趙玉沛,蔡力行,等. 胰腺癌細胞對化療藥物敏感性的測定 [J]. 中華實驗外科雜志, 1998; 15(5)44411 Lee JH, Takahashi T, Yasuhara N, et al. Bis, a Bcl2binding protein that synergizes with Bcl2 in preventing cell death [J]. Oncogene, 1999; 18(46)618312 Doong H, Price J, Kim YS, et al. CAIR1/BAG3 forms an EGFregulated ternary complex with phospholipase Cgamma and Hsp70/Hsc70 [J]. Oncogene, 2000; 19(38)4385.
|